- Home
- BNBX vs XXII Comparison
BNBX vs XXII Comparison
Compare BNBX & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNBX | XXII |
|---|---|---|
| Founded | 1983 | 1998 |
| Country | United States | United States |
| Employees | 26 | N/A |
| Industry | Other Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 3.3M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | BNBX | XXII |
|---|---|---|
| Price | $0.64 | $2.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 40.8K | 35.5K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 69.96 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $25,832,530.00 |
| Revenue This Year | $253.12 | N/A |
| Revenue Next Year | N/A | $79.56 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.61 | $0.67 |
| 52 Week High | $6.17 | $11.37 |
Technical Indicators
Market Signals| Indicator | BNBX | XXII |
|---|---|---|
| Relative Strength Index (RSI) | 31.01 | 24.92 |
| Support Level | $0.61 | $2.18 |
| Resistance Level | $0.85 | $2.67 |
| Average True Range (ATR) | 0.06 | 0.27 |
| MACD | 0.00 | -0.13 |
| Stochastic Oscillator | 3.59 | 12.68 |
Price Performance
Historical ComparisonAbout BNBX Applied DNA Sciences Inc.
BNB Plus Corp focuses on digital asset treasury management of BNB. The group is unlocking institutional-grade access to the Binance ecosystem, delivering non-directional yield strategies and long BNB exposure, powering the future of blockchain through a transparent, actively managed BNB treasury. The Company's differentiated blends sophisticated DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded from the space.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.